WEST PHARMACEUTICAL SERVICES INC (WST) Income Tax Expense (Benefit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
West Pharmaceutical Services Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
  • West Pharmaceutical Services Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $16.4 M, a 30.5% decline year-over-year.
  • West Pharmaceutical Services Inc Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $115 M, a 1.71% decline year-over-year.
  • West Pharmaceutical Services Inc annual Income Tax Expense (Benefit) for 2023 was $122 M, a 6.63% increase from 2022.
  • West Pharmaceutical Services Inc annual Income Tax Expense (Benefit) for 2022 was $115 M, a 7% increase from 2021.
  • West Pharmaceutical Services Inc annual Income Tax Expense (Benefit) for 2021 was $107 M, a 47.9% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $115 M $16.4 M -$7.2 M -30.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $122 M $34.5 M +$5.6 M +19.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $117 M $29.4 M +$9 M +44.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $108 M $34.8 M -$9.4 M -21.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $117 M $23.6 M +$2.4 M +11.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $115 M $28.9 M -$5.3 M -15.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $120 M $20.4 M +$8.4 M +70% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $112 M $44.2 M +$11.9 M +36.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $99.7 M $21.2 M -$7.5 M -26.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $107 M $34.2 M +$13.8 M +67.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $93.4 M $12 M -$9.1 M -43.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $103 M $32.3 M +$16.3 M +102% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $86.2 M $28.7 M +$13.7 M +91.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $72.5 M $20.4 M +$3.9 M +23.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $68.6 M $21.1 M +$10.2 M +93.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $58.4 M $16 M +$500 K +3.23% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $57.9 M $15 M -$1.1 M -6.83% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $59 M $16.5 M +$1.6 M +10.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-22
Q3 2019 $57.4 M $10.9 M +$2.9 M +36.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-23
Q2 2019 $54.5 M $15.5 M +$9.5 M +158% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-24
Q1 2019 $45 M $16.1 M +$3.6 M +28.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-24
Q4 2018 $41.4 M $14.9 M -$46.9 M -75.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $88.3 M $8 M -$6 M -42.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-29
Q2 2018 $94.3 M $6 M +$3.1 M +107% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-29
Q1 2018 $91.2 M $12.5 M +$10.3 M +468% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $80.9 M $61.8 M +$45.7 M +284% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $35.2 M $14 M -$400 K -2.78% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $35.6 M $2.9 M -$14.1 M -82.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $49.7 M $2.2 M -$4.7 M -68.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $54.4 M $16.1 M +$4.9 M +43.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $49.5 M $14.4 M +$21 M Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $28.5 M $17 M +$7.8 M +84.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $20.7 M $6.9 M -$5.6 M -44.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $26.3 M $11.2 M -$500 K -4.27% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $26.8 M -$6.6 M -$18.3 M -156% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-31
Q2 2015 $45.1 M $9.2 M -$4.8 M -34.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 $49.9 M $12.5 M +$2.7 M +27.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $47.2 M $11.7 M +$1 M +9.35% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $46.2 M $11.7 M +$1.1 M +10.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $45.1 M $14 M +$3.7 M +35.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-03
Q1 2014 $41.4 M $9.8 M +$1.2 M +14% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $40.2 M $10.7 M +$3.3 M +44.6% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $36.9 M $10.6 M +$1.6 M +17.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-03
Q2 2013 $35.3 M $10.3 M +$3.8 M +58.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 $31.5 M $8.6 M -$1.2 M -12.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $32.7 M $7.4 M +$1.9 M +34.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $30.8 M $9 M +$2.4 M +36.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-04
Q2 2012 $28.4 M $6.5 M +$1.2 M +22.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 $27.2 M $9.8 M +$3.7 M +60.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q4 2011 $23.5 M $5.5 M +$9.2 M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-27
Q3 2011 $14.3 M $6.6 M +$2.1 M +46.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 $12.2 M $5.3 M -$1.3 M -19.7% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-06
Q1 2011 $13.5 M $6.1 M -$100 K -1.61% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 $13.6 M -$3.7 M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $4.5 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $6.6 M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-08
Q1 2010 $6.2 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.